Pay in 4 interest-free payments of $7.21 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
These changes occur at the 2nd, 8th, 15th, and 27th positions and are believed to possibly enhance the peptides stability against enzymatic degradation, particularly from enzymes like dipeptidyl peptidase-4 (DPP-4)
These medications are also not recommended during breastfeeding
Fiscal full-year 2025 revenue is expected to be between $235 million and $245 million versus the consensus estimate of $204.3 million
These new medications increase satiety, meaning the feeling of fullness or satisfaction after a meal
Results Retatrutide markedly reduced body weight and adiposity and improved metabolic parameters including glucose homeostasis and dyslipidemia
US$ 23.30
US$ 20.58
US$ 21.51
US$ 26.49
US$ 22.93
US$ 20.25
US$ 27.82
